FDA Issues Warning Letter Accusing JUUL of Marketing Products to Students as ‘Safe’




WASHINGTON, D.C. — The Food and Drug Administration has issued a warning letter to JUUL Labs Inc., accusing it of marketing unauthorized modified risk tobacco products to consumers, including youths in schools, touting the products as “much safer than cigarettes.”

In the Sept. 9 letter, the FDA said JUUL adulterated its electronic nicotine delivery system (ENDS) products under Section 902(8) of the Food, Drug and Cosmetic Act by selling or distributing them as modified risk tobacco products without an FDA order that permits such sale or distribution.

The agency added that testimony from a July House of Representatives subcommittee hearing …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS